Evaluating mucosal humoral immunity is important for understanding local im
munity induced by HIV infection or vaccination and designing prophylactic s
trategies. To characterize the mucosal humoral immunity following HIV infec
tion, the levels of immunoglobulins (Igs), antibodies (Abs), and HIV1-speci
fic Ab activity were evaluated in cervicovaginal secretions (CVS), saliva,
breast milk, and sera of HIV-infected individuals. HIV1-specific IgG: activ
ity was significantly higher than that of IgA in CVS, saliva, and breast mi
lk. The highest HIV1-specific IgG activity was found in breast milk. The da
ta suggest that anti-HIV1 Abs in CVS were most likely serum derived. Howeve
r, HIV1-specific Abs in saliva and breast milk were mainly locally produced
. The prevalence of HIV1-specific Abs in seropositive subjects was 97% for
IgG and 95% for IgA in CVS, 100% for IgG and 80% for IgA in saliva, and 59%
for IgG and 94% for IgA in breast milk. These data provide evidence for bo
th a better understanding of the nature of humoral mucosal responses after
HIV1 infection and the development of strategies to induce desirable functi
onal mucosal immunity for preventing HIV transmission. (C) 2000 Academic Pr
ess.